A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)

✍ Scribed by R.E. Coleman; L. Biganzoli; P. Canney; L. Dirix; L. Mauriac; P. Chollet; V. Batter; E. Ngalula-Kabanga; C. Dittrich; M. Piccart

• Book ID: 116428872
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 117 KB
• Volume: 42
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2005.12.011